HBM Holdings H1 revenue rises amid mid-to-late clinical program progress
HBM Holdings says its H1 revenue rose as progress continues on mid-to-late clinical stage programs.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.